insights_auto
Why is ARX up २.५४%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
A$ ०.५०
arrow_upward
+२.५४%(+०.०१२) 1D
नोभेम्बर १८, १६:००:०० GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$ ०.५०
High
A$ ०.५१
Low
A$ ०.४९
Mkt. cap
१६.८७ करोड
Avg. vol.
२.६० लाख
Volume
२.३८ लाख
P/E ratio
४८.१०
52-wk high
A$ ०.७८
52-wk low
A$ ०.४६
EPS
A$ ०.०१
Shares outstanding
३४.५९ करोड
No. of employees
२६१
Open
A$ ०.५०
High
A$ ०.५१
Low
A$ ०.४९
Mkt. cap
१६.८७ करोड
Avg. vol.
२.६० लाख
Volume
२.३८ लाख
P/E ratio
४८.१०
52-wk high
A$ ०.७८
52-wk low
A$ ०.४६
EPS
A$ ०.०१
Shares outstanding
३४.५९ करोड
No. of employees
२६१
News stories
From web sources and news partners
ChartMill
·
१ घण्टा पहिले
S&P 500 Gap-Down Movers for Nov. 18 Session
TradingView
·
१ घण्टा पहिले
S&P 500, Nasdaq find footing as Nvidia treads water
Stocktwits
·
१ घण्टा पहिले
S&P 500 Could Hit 8,200 By End Of 2027, Says UBS — Warns Of 5,500 In ‘AI Bust’ Scenario
Proactive financial news
·
४५ मिनेट पहिले
MARKETS LIVE: Dow losses deepen and S&P 500 turns lower as gold slides
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd